These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3388293

  • 1. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
    Daly HM, Haddon ME.
    Thromb Haemost; 1988 Apr 08; 59(2):171-4. PubMed ID: 3388293
    [Abstract] [Full Text] [Related]

  • 2. A pasteurised concentrate of human plasma factor XIII for therapeutic use.
    Winkelman L, Sims GE, Haddon ME, Evans DR, Smith JK.
    Thromb Haemost; 1986 Jun 30; 55(3):402-5. PubMed ID: 3750269
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of congenital insufficiency in fibrin stabilising factor (FSF or factor XIII) by purified factor XIII of placental origin. Report of two cases with a four year follow up].
    Caille B, Vergoz D, Vie JC, Braive JP, Capron F, Duriez S, Sarrade-Loucheur C, Ferrer F.
    Ann Pediatr (Paris); 1977 Dec 30; 24(12):837-42. PubMed ID: 16218265
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C, Chang E, Davis J, Mangione A, Frame V, Nugent DJ.
    Haemophilia; 2015 Jan 30; 21(1):102-8. PubMed ID: 25377187
    [Abstract] [Full Text] [Related]

  • 5. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
    Onland W, Böing AN, Meijer AB, Schaap MC, Nieuwland R, Haasnoot K, Sturk A, Peters M.
    Haemophilia; 2005 Sep 30; 11(5):539-47. PubMed ID: 16128900
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution.
    Morange P, Trigui N, Frère C, Chambost H, Pouymayou C, Uters M, Boucly C, Juhan-Vague I, de Mazancourt P.
    Blood Coagul Fibrinolysis; 2009 Oct 30; 20(7):605-6. PubMed ID: 19713833
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic factor XIII preparations and perspectives for recombinant factor XIII.
    Karges HE, Metzner HJ.
    Semin Thromb Hemost; 1996 Oct 30; 22(5):427-36. PubMed ID: 8989827
    [Abstract] [Full Text] [Related]

  • 13. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
    Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H.
    Gynecol Obstet Invest; 1990 Oct 30; 29(3):235-8. PubMed ID: 2358199
    [Abstract] [Full Text] [Related]

  • 14. The half life of factor XIII in the management of inherited deficiency.
    Fear JD, Miloszewski KJ, Losowsky MS.
    Thromb Haemost; 1983 Apr 28; 49(2):102-5. PubMed ID: 6868004
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A short half-life of the administered factor XIII (FXIII) concentrates after the first replacement therapy in a newborn with severe congenital FXIII deficiency.
    Fujii N, Souri M, Ichinose A.
    Thromb Haemost; 2012 Mar 28; 107(3):592-4. PubMed ID: 22234520
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.